STAT News · Scour

STAT+: Kennedy focuses on affordability, combating fraud in Capitol Hill hearing

statnews.com·4w

STAT+: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target

statnews.com·4w

STAT+: Cochrane review reignites Alzheimer’s amyloid wars

statnews.com·4w

STAT+: RFK Jr. begins his testimony marathon

statnews.com·4w

STAT+: Pharmalittle: We’re reading about a review of Alzheimer’s drugs, FDA interest in compounded peptides, and more

statnews.com·4w

STAT+: Medicare may nix breakthrough device payment pathway

statnews.com·4w

The mental health parity gap is gaping

statnews.com·4w

STAT+: Roche to launch another Elevidys trial, with eyes on European approval

statnews.com·4w

STAT+: Travere’s drug for a kidney disease doesn’t improve kidney function. The FDA approved it anyway

statnews.com·4w

STAT+: 7 key issues we’re watching as RFK Jr. faces a Congressional gauntlet

statnews.com·4w

Opinion: STAT+: The medical AI revolution requires rethinking health care’s architecture

statnews.com·4w

Opinion: Voice-first chatbots will exacerbate AI’s mental health threat

statnews.com·4w

STAT+: CMS proposes rolling back breakthrough device payment flexibilities

statnews.com·4w

STAT+: Novartis CEO joins Anthropic’s board

statnews.com·4w

STAT+: FDA panel will meet to discuss allowing broader access to certain peptides

statnews.com·4w

STAT+: A $15 AI test, Project Glasswing, and how Doctronic pilot blindsided Utah medical board

statnews.com·4w

STAT+: Pharmalittle: We’re reading about FDA seeking more data on a Lilly obesity pill, a pharma 340B win, and more

statnews.com·4w

Trump DOJ report says Biden administration treated anti-abortion protestors unfairly

statnews.com·4w

STAT+: New Bain biotech startup, building on BMS drugs, gets a name and a CEO

statnews.com·4w

Opinion: Medical schools must continue to teach students about structural barriers to care

statnews.com·4w

Log in to enable infinite scrolling